These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32900513)
1. [Diabetes and COVID-19 in the elderly, harmful symbiosis]. Formiga F; Tarazona-Santabalbina FJ Rev Esp Geriatr Gerontol; 2020; 55(6):315-316. PubMed ID: 32900513 [No Abstract] [Full Text] [Related]
2. COVID-19 and cardiovascular disease. Guijarro C Clin Investig Arterioscler; 2020; 32(6):263-266. PubMed ID: 33213825 [No Abstract] [Full Text] [Related]
3. Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics. Gomes CP; Fernandes DE; Casimiro F; da Mata GF; Passos MT; Varela P; Mastroianni-Kirsztajn G; Pesquero JB Front Cell Infect Microbiol; 2020; 10():589505. PubMed ID: 33364201 [TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus: Lessons from the COVID-19 pandemic. Tousoulis D Hellenic J Cardiol; 2020; 61(1):1-2. PubMed ID: 32425483 [No Abstract] [Full Text] [Related]
5. Platelets and renal failure in the SARS-CoV-2 syndrome. Taha M; Sano D; Hanoudi S; Esber Z; Elahi M; Gabali A; Chopra T; Draghici S; Samavati L Platelets; 2021 Jan; 32(1):130-137. PubMed ID: 32892687 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19? Hu Y; Liu L; Lu X Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update. Shukla AK; Banerjee M High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533 [TBL] [Abstract][Full Text] [Related]
9. A potential therapeutic combination for treatment of COVID-19: Synergistic effect of DPP4 and RAAS suppression. Phyu Khin P; Cha SH; Jun HS; Lee JH Med Hypotheses; 2020 Nov; 144():110186. PubMed ID: 33254506 [TBL] [Abstract][Full Text] [Related]
10. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? Esler M; Esler D J Hypertens; 2020 May; 38(5):781-782. PubMed ID: 32195824 [No Abstract] [Full Text] [Related]
11. Receptor utilization of angiotensin-converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV. Wang Q; Qiu Y; Li JY; Liao CH; Zhou ZJ; Ge XY Transbound Emerg Dis; 2021 May; 68(3):1046-1053. PubMed ID: 32794346 [TBL] [Abstract][Full Text] [Related]
12. Statins in COVID-19: is there any foundation? Lima Martínez MM; Contreras MA; Marín W; D'Marco L Clin Investig Arterioscler; 2020; 32(6):278-281. PubMed ID: 32718669 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy. Xie L; Zhang Z; Wang Q; Chen Y; Lu D; Wu W Front Endocrinol (Lausanne); 2021; 12():772865. PubMed ID: 34867819 [TBL] [Abstract][Full Text] [Related]
14. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer's Disease. Ding Q; Shults NV; Gychka SG; Harris BT; Suzuki YJ Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567524 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme 2 as a versatile player in the management of coronavirus disease 2019. Amano T J Diabetes Investig; 2020 Sep; 11(5):1120-1122. PubMed ID: 32657484 [No Abstract] [Full Text] [Related]